A Prospectively Randomized Phase III Study on Adjuvant Chemotherapy and Adjuvant Chemo-Immunotherapy in Patients With Operated Colon Carcinoma Dukes C (Stage III; T1-4, N1-30, M0).
Interventional
Allocation: Randomized, Intervention Model: Factorial Assignment, Masking: Open Label, Primary Purpose: Treatment
Recurrence-free survival
Raimund Jakesz, MD
Principal Investigator
Austrian Breast & Colorectal Cancer Study Group
Austria: Federal Ministry for Health and Women
ABCSG 90
NCT00309530
October 1990
Name | Location |
---|